SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD has a total of 18 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are CARBIOTIX AB, TEGA THERAPEUTICS INC and DEANGELIS PAUL L.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | United States | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Macromolecular chemistry and polymers | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Fermentation | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Medical preparations | |
#6 | Polysaccharides | |
#7 | Measuring microorganism processes | |
#8 | Microorganisms | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Li Li | 16 |
#2 | Lin Senmao | 7 |
#3 | Bai Jiake | 7 |
#4 | Ma Xiaolai | 6 |
#5 | Luo Junjun | 4 |
#6 | Shi Ying | 4 |
#7 | Gao Jinliang | 4 |
#8 | Wang Jingwen | 3 |
#9 | Jin Xuewen | 3 |
#10 | Zhang Lili | 3 |
Publication | Filing date | Title |
---|---|---|
WO2020020145A1 | Method for analyzing sugar chain distribution of low molecular heparin and use thereof | |
WO2020020152A1 | Method for analyzing nitrous acid degradation product of dalteparin sodium and application thereof | |
CN111670038A | Glycosaminoglycan derivatives, process for their preparation and their use | |
EP3561048A1 | Heparinase producing pseudomonas stutzeri strain and heparinase derived therefrom | |
CN108239629A | Heparinase and its preparation and application from Sphingobacterium spiritivorum | |
WO2017113197A1 | Sulfated heparin oligosaccharide and preparation method and application thereof |